Prospect News: News for Pharmaceutical Resources

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Price: $0.00

Account balance: $0.00

Add to balance / Manage account

User: lxbfYeaa

Log out

Prospect News home > Main news index > All issuers starting with P > Issuers starting with P, CV only > All stories on Pharmaceutical Resources > Stories on Pharmaceutical Resources, CV only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Pharmaceutical Resources

4/13/2004	CV	Market Commentary: Caesars, Sallie Mae floaters up on rate hike concerns; Pharma Resources dives as outlook cut
4/12/2004	CV	Market Commentary: Pharma Resources rocked, ends flat on generic drug competition; Komag gains on better outlook
9/29/2003	CV	Pharmaceutical Resources greenshoe exercised, raising convertibles to $200 million
9/29/2003	CV	Market Commentary: Gap, Charming Shoppes show mixed views on retail results; Pharma Resources gains 2.25
9/26/2003	CV	Market Commentary: Market not ready to swallow Bristol-Myers Squibb; Cracker Barrel drops 1.5 on dividend
9/25/2003	CV	New Issue: Pharmaceutical Resources sells upsized $160 million convertible at 2.875%, up 35%
9/25/2003	CV	Market Commentary: Pharma Resources gains to 104 despite complaint; Bristol-Myers jumbo seen offered at par in gray
9/24/2003	CV	Pharma Resources $150 million convertible talked at 2.75-3.25%, up 33-37%
9/24/2003	CV	Market Commentary: CKE bids beefed up to 107; Flextronics expected to lose "big points" on jury award

©2026 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.